Strategic Meeting during this week between the Shareholders of Probiomed (Mexico) and AXXO in order to discuss our future strategy regarding the development and distribution of our Biotechnology Portfolio – with the focus especially on the Monoclonal Antibody Products. The fundament of our company is built on trust and on the experience of a dynamic, multi-disciplinary and highly qualified team. The application of a unified work methodology, with a focus on quality in everything we do. Thank you for such a great visit in Hamburg at the AXXO Headquarter.